Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04195906 · ClinicalTrials.gov registry record · Phase 3
Phase 3 Study of SNF472 for Calciphylaxis
A Phase 3 study, sponsored by Sanifit Therapeutics S. A..
- Completed
- Registry status
- Phase 3
- Development phase
- 71
- Enrollment target
NCT04195906: Completed Phase 3 study, sponsored by Sanifit Therapeutics S. A..
NCT04195906 is a Phase 3 study that has completed, run by Sanifit Therapeutics S. A.. The registered enrollment target is 71 participants, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (91% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04195906, a Phase 3 study, has completed, sponsored by Sanifit Therapeutics S. A..
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 71 participants
- Enrollment target
Study Summary
The primary objectives are to assess the efficacy, safety, and tolerability of SNF472 compared to placebo when added to background care for the treatment of calciphylaxis (CUA).
Primary Outcome
The Bates Jensen Wound Assessment Tool (BWAT) CUA score ranges from a minimum score of 8 (best) to a maximum score of 40 (worst). BWAT-CUA= Bates-Jensen Wound Assessment Tool-Calcific Uremic Arteriolopathy
Interventions
- DRUG Placebo Comparator: Placebo
- DRUG Experimental: SNF472
- DRUG Experimatenl SNF472 (Open-label)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 71 participants |
| Start Date | 2020-02-12 |
| Est. Completion | 2022-10-24 |
| Phase | Phase 3 |
What the finished NCT04195906 record still lists
NCT04195906 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 71 participants, a relatively small participant target, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (91% lower).
The record links to 0 conditions, and to 3 interventions - of which Placebo Comparator: Placebo is the first listed.
NCT04195906 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04195906 about?
NCT04195906 is a clinical study titled "Phase 3 Study of SNF472 for Calciphylaxis". The primary objectives are to assess the efficacy, safety, and tolerability of SNF472 compared to placebo when added to background care for the treatment of calciphylaxis (CUA).
What is the current status of trial NCT04195906?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 71 participants. The study started on 2020-02-12. Estimated completion is 2022-10-24.
What interventions are being tested in trial NCT04195906?
The interventions under investigation include: Placebo Comparator: Placebo (DRUG), Experimental: SNF472 (DRUG), Experimatenl SNF472 (Open-label) (DRUG).
Who is sponsoring clinical trial NCT04195906?
This trial is sponsored by Sanifit Therapeutics S. A., which has 4 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04195906's enrollment target sits among peer trials
71 1784th of 2000 higher than 216 of 2,000 other Phase 3 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 3 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05452889 · 71 participants · Early Phase 1
PET Image in PAH Patients
- NCT05766943 · 71 participants · NA
Reduction of Myopotential Interference With Smart Pass in S-ICD Patients
- NCT06229678 · 71 participants · Early Phase 1
Ketones, SGLT2, HFrEF
- NCT06377566 · 71 participants · Phase 2
A Study of BV-AVD in People With Bulky Hodgkin Lymphoma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI